These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis. Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517 [No Abstract] [Full Text] [Related]
7. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results]. Oliw E; Wollheim FA Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877 [No Abstract] [Full Text] [Related]
8. [Celebrex: confirmed effectiveness and safety (new data)]. Nasonov EL Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753 [No Abstract] [Full Text] [Related]
9. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition]. MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613 [No Abstract] [Full Text] [Related]
10. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. Tindall E J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176 [TBL] [Abstract][Full Text] [Related]
11. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart]. MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204 [No Abstract] [Full Text] [Related]
12. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
14. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V; Hutchins B Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
15. COX-2 inhibitors. Brooks PM; Day RO Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038 [TBL] [Abstract][Full Text] [Related]
16. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Maetzel A; Krahn M; Naglie G Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781 [TBL] [Abstract][Full Text] [Related]
17. [Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis. Results of a post-marketing surveillance]. Wigand R; Wehling M; Brauer HG; Stridde E; Vergin H; May M Dtsch Med Wochenschr; 2004 May; 129(21):1188-92. PubMed ID: 15160322 [TBL] [Abstract][Full Text] [Related]
18. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]
19. [COX-2 inhibitors: a new treatment in rheumatic diseases]. Puddu G; Cravero E Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282 [TBL] [Abstract][Full Text] [Related]
20. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)]. Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902 [No Abstract] [Full Text] [Related] [Next] [New Search]